Company
Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| NPI-001 | Phase 3 | Retinitis Pigmentosa (RP) |
Latest
No recent events.
Follow Nacuity Pharmaceuticals, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.